MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill?

Poul Flemming Høilund‐Carlsen; Abass Alavi; George Perry; Jorge R. Barrio

doi:10.3174/ajnr.a7702

Abstract

1 min read

In a recent article in the American Journal of Neuroradiology, Cogswell et al[1][1] urged radiologists to learn about amyloid-related imaging abnormalities (ARIAs) and their MR imaging appearance to be able to diagnose and monitor cerebral changes observed in patients with Alzheimer disease treated

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2023

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls

Poul Flemming Høilund‐Carlsen, Mona‐Elisabeth Revheim, Tommaso Costa, Kasper P. Kepp, Rudolph J. Castellani, George Perry, Abass Alavi, Jorge R. Barrio

Article2000

Prospects for Noninvasive Imaging of Brain Amyloid β in Alzheimer's Disease

Robert P. Friedland, Jiong Shi, Joseph C. LaManna, Mark A. Smith, George Perry

Article2018

P1‐137: REDUCED ENTORHINAL GRAY MATTER VOLUME IN HEALTHY AMYLOID‐NEGATIVE <i>APOE‐E4</i> HOMOZYGOTES OF THE ALFA COHORT

Juan Domingo Gispert, Gemma Salvadó, Raffaele Cacciaglia, Grégory Operto, Carles Falcón, Anna Brugulat, Oriol Grau‐Rivera, Marc Suárez‐Calvet, Sebastián Morán, Manel Esteller, José Luís Molinuevo

Article2018

O2‐08‐03: LIFETIME MEASURES OF RESERVE ATTENUATE CORTISOL AND β‐AMYLOID‐RELATED RISK OF ALZHEIMER'S DISEASE CLINICAL PROGRESSION FROM THE PRE‐SYMPTOMATIC PHASE

Chinedu Udeh‐Momoh, Bowen Su, Stephanie Evans, Bang Zheng, Shireen Sindi, Robert Perneczky, Elio Riboli, Lefkos Middleton

Letter2016

Modulation of Parkinson’s Disease Associated Protein Rescues Alzheimer’s Disease Degeneration

Akihiko Nunomura, Xiongwei Zhu, George Perry